Current Imaging Strategies of Primary and Secondary Neoplasms of the Liver

ABSTRACT

This article details the diagnosis and imaging of primary and secondary neoplasms of the liver. Benign conditions that can mimic malignancy are also discussed, such as focal nodular hyperplasia and adenoma. Considerable attention is given to hepatoma, which is the most common primary hepatic tumor in the United States. The roles of magnetic resonance imaging, computed tomography, and ultrasound are evaluated, with recommendations for their effective use. Pitfalls in imaging related to posttreatment changes and unusual patterns of metastatic disease are illustrated.

KEYWORDS

Cancer - liver - hepatoma - imaging - metastasis

REFERENCES

• 1 American Cancer Society .Cancer Facts and Figures 2005. Atlanta, GA; American Cancer Society 2005
• 2 Chen C J, Yu M W, Liaw Y F. Epidemiological characteristics and risk factors of hepatocellular carcinoma.  J Gastroenterol Hepatol. 1997;  12 S294-S308
• 3 Michielsen P P, Francque S M, van Dongen J L. Viral hepatitis and hepatocellular carcinoma.  World J Surg Oncol. 2005;  3 27
• 4 Beasley R P, Hwang L Y, Lin C C, Chien C S. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan.  Lancet. 1981;  2 1129-1133
• 5 Cha C, Dematteo R P. Molecular mechanisms in hepatocellular carcinoma development.  Best Pract Res Clin Gastroenterol. 2005;  19 25-37
• 6 Karayiannis P. Hepatitis D virus.  Rev Med Virol. 1998;  8 13-24
• 7 McGlynn K A, London W T. Epidemiology and natural history of hepatocellular carcinoma.  Best Pract Res Clin Gastroenterol. 2005;  19 3-23
• 8 Moradpour D, Blum H E. Pathogenesis of hepatocellular carcinoma.  Eur J Gastroenterol Hepatol. 2005;  17 477-483
• 9 Daniele B, Bencivenga A, Megna A S, Tinessa V. Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma.  Gastroenterology. 2004;  127(suppl 1) S108-S112
• 10 Schefer H, Mattmann S, Joss R A. Hereditary persistence of alpha-fetoprotein: case report and review of the literature.  Ann Oncol. 1998;  9 667-672
• 11 Peng S Y, Chen W J, Lai P L, Jeng Y M, Sheu J C, Hsu H C. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.  Int J Cancer. 2004;  112 44-50
• 12 Oliver III J H, Baron R L, Federle M P, Rockette Jr H E. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging.  AJR Am J Roentgenol. 1996;  167 71-77
• 13 Scharitzer M, Schima W, Schober E et al.. Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging.  J Comput Assist Tomogr. 2005;  29 181-190
• 14 Saini S, Edelman R R, Sharma P et al.. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).  AJR Am J Roentgenol. 1995;  164 1147-1152
• 15 The Cancer of the Liver Italian Program (CLIP) investigators . A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients.  Hepatology. 1998;  28 751-755
• 16 Kudo M, Chung H, Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).  J Gastroenterol. 2003;  38 207-215
• 17 Liovet J M, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the Barcelona clinic liver cancer staging classification.  Semin Liver Dis. 1999;  19 329-338
• 18 American Joint Committee on Cancer . Liver (including intrahepatic bile ducts). In: Green FL, Page DL, Fleming ID, et al AJCC Staging Manual. 6th ed. New York; Springer 2002: 131-138
• 19 Craig J R, Peters R L, Edmondson H A, Omata M. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features.  Cancer. 1980;  46 372-379
• 20 El-Serag H B, Davila J A. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.  Hepatology. 2004;  39 798-803
• 21 McLarney J K, Rucker P T, Bender G N et al.. Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation.  Radiographics. 1999;  19 453-471
• 22 Gabata T, Matsui O, Kadoya M et al.. Delayed MR imaging of the liver: correlation of delayed enhancement of hepatic tumors and pathologic appearance.  Abdom Imaging. 1998;  23 309-313
• 23 Altaee M Y, Johnson P J, Farrant J M, Williams R. Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma.  Cancer. 1991;  68 2051-2055
• 24 Hayasaka K, Amoh K, Kakisaka A, Mito M. MRI appearance of thorotrast-induced cholangiocarcinoma in a case of thorotrastosis.  Radiat Med. 1993;  11 60-62
• 25 Yalcin S. Diagnosis and management of cholangiocarcinomas: a comprehensive review.  Hepatogastroenterology. 2004;  51 43-50
• 26 Di Cesare E, Puglielli E, Michelini O et al.. Malignant obstructive jaundice: comparison of MRCP and ERCP in the evaluation of distal lesions.  Radiol Med (Torino). 2003;  105 445-453
• 27 Yeh T S, Jan Y Y, Tseng J H et al.. Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings.  Am J Gastroenterol. 2000;  95 432-440
• 28 Gore R M, Yaghmai V, Newmark G M, Berlin J W, Miller F H. Imaging benign and malignant disease of the gallbladder.  Radiol Clin North Am. 2002;  40 1307-1323
• 29 Paraskevopoulos J A, Dennison A R, Johnson A G. Primary carcinoma of the gallbladder.  HPB Surg. 1991;  4 277-289
• 30 Crippa S, Bovo G, Romano F, Mussi C, Uggeri F. Melanoma metastatic to the gallbladder and small bowel: report of a case and review of the literature.  Melanoma Res. 2004;  14 427-430
• 31 Chiu O, Frank J D, Dow C A. Hepatic angiosarcoma: detection with computed tomography.  Australas Radiol. 2005;  49 163-165
• 32 Hozo I, Miric D, Bojic L et al.. Liver angiosarcoma and hemangiopericytoma after occupational exposure to vinyl chloride monomer.  Environ Health Perspect. 2000;  108 793-795
• 33 Azodo M V, Gutierrez O H, Greer T. Thorotrast-induced ruptured hepatic angiosarcoma.  Abdom Imaging. 1993;  18 78-81
• 34 Harrison J R, Faust T W, Blackstone M O. Hepatic angiosarcoma: an unusual cause of congestive heart failure.  South Med J. 2001;  94 336-338
• 35 Emre S, McKenna G J. Liver tumors in children.  Pediatr Transplant. 2004;  8 632-638
• 36 Fukuzawa R, Hata J, Hayashi Y, Ikeda H, Reeve A E. Beckwith-Wiedemann syndrome-associated hepatoblastoma.  Pediatr Dev Pathol. 2003;  6 299-306
• 37 Yamazaki M, Ryu M, Okazumi S et al.. Hepatoblastoma in an adult: a case report and clinical review of literatures.  Hepatol Res. 2004;  30 182-188
• 38 Choi B Y, Nguyen M H. The diagnosis and management of benign hepatic tumors.  J Clin Gastroenterol. 2005;  39 401-412
• 39 Yoon S S, Charny C K, Fong Y et al.. Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma.  J Am Coll Surg. 2003;  197 392-402
• 40 Bonanno N, Baldari S, Cerrito A et al.. Diagnosis of hepatic hemangiomas with 99mTc-labeled red blood cell scanning: value of SPECT.  J Nucl Biol Med. 1991;  35 135-140
• 41 Kim T, Federle M P, Baron R L, Peterson M S, Kawamori Y. Discrimination of small hepatic hemangiomas from hypervascular malignant tumors smaller than 3 cm with three-phase helical CT.  Radiology. 2001;  219 699-706
• 42 Yan F H, Zeng M S, Zhou K R. Role and pitfalls of hepatic helical multi-phase CT scanning in differential diagnosis of small hemangioma and small hepatocellular carcinoma.  World J Gastroenterol. 1998;  4 343-347
• 43 Shortell C K, Schwartz S I. Hepatic adenoma and focal nodular hyperplasia.  Surg Gynecol Obstet. 1991;  173 426-431
• 44 Minami Y, Kudo M, Kawasaki T et al.. Intrahepatic huge hematoma due to rupture of small hepatocellular adenoma: a case report.  Hepatol Res. 2002;  23 145-151
• 45 Grazioli L, Federle M P, Ichikawa T, Balzano E, Nalesnik M, Madariaga J. Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients.  Radiology. 2000;  216 395-402
• 46 Grazioli L, Federle M P, Brancatelli G, Ichikawa T, Olivetti L, Blachar A. Hepatic adenomas: imaging and pathologic findings.  Radiographics. 2001;  21 877-892
• 47 Paulson E K, McClellan J S, Washington K, Spritzer C E, Meyers W C, Baker M E. Hepatic adenoma: MR characteristics and correlation with pathologic findings.  AJR Am J Roentgenol. 1994;  163 113-116
• 48 Reddy K R, Kligerman S, Levi J et al.. Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome.  Am Surg. 2001;  67 173-178
• 49 Blachar A, Federle M P, Ferris J V et al.. Radiologists' performance in the diagnosis of liver tumors with central scars by using specific CT criteria.  Radiology. 2002;  223 532-539
• 50 Finley A C, Hosey J R, Noone T C, Shackelford D M, Varadarajulu S. Multiple focal nodular hyperplasia syndrome: diagnosis with dynamic, gadolinium-enhanced MRI.  Magn Reson Imaging. 2005;  23 511-513
• 51 Basaran C, Karcaaltincaba M, Akata D et al.. Fat-containing lesions of the liver: cross-sectional imaging findings with emphasis on MRI.  AJR Am J Roentgenol. 2005;  184 1103-1110
• 52 Krakora G A, Coakley F V, Williams G, Yeh B M, Breiman R S, Qayyum A. Small hypoattenuating hepatic lesions at contrast-enhanced CT: prognostic importance in patients with breast cancer.  Radiology. 2004;  233 667-673
• 53 Mortele K J, Ros P R. Cystic focal liver lesions in the adult: differential CT and MR imaging features.  Radiographics. 2001;  21 895-910
• 54 Brannigan M, Burns P N, Wilson S R. Blood flow patterns in focal liver lesions at microbubble-enhanced US.  Radiographics. 2004;  24 921-935
• 55 Li L, Liu L Z, Xie Z M et al.. Multi-phasic CT arterial portography and CT hepatic arteriography improving the accuracy of liver cancer detection.  World J Gastroenterol. 2004;  10 3118-3121
• 56 Kim H C, Kim T K, Sung K B et al.. CT during hepatic arteriography and portography: an illustrative review.  Radiographics. 2002;  22 1041-1051